Pharmaceuticals Krka With Nearly EUR 50M Net Profit in 2002
Novo Mesto, 31 March - Leading Slovenian pharmaceutical maker Krka Group recorded SIT 88.33bn (EUR 380.5m) in sales revenues last year, of which 23 percent came from the domestic market and 77 percent from abroad. The group's net profit totalled SIT 11.08bn (EUR 47.7m), a rise of 29 percent over the year before.
The rest of this news item is available to subscribers.
The news item consists of 1.123 characters (without spaces) or 193 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.